Filters
Product Categories
Presented by: Tereza Hubkov, MD
As pharmaceuticals continue to be disappointing when it comes to prevention or treatment of dementia, or they are plagued with significant side effects, it is time to return to the many natural treatments used by our ancestors for many centuries and now increasingly more validated by modern research. Adaptogenic, nootropic plants, mushrooms, foods and culinary spices have shown significant ability to minimize the pathology of Alzheimer’s dementia, Parkinson’s disease, and other brain health disorders. In this session, participants will learn about the health benefits and safety of Ashwagandha, Reishi, Rhodiola, Schizandra, Lion’s mane, Bacopa, turmeric, garlic, sage, and cinnamon, to name just a few of nature’s broad apothecary.
In 1996, the question originated from Dr. Eli A Friedman’s article, “can the Bowel act as a kidney substitute in advance renal failure?” prior to the discovery of the gut microbiome. The bowel was recognized as an organ in 2004 in Proceedings of the National Academy of Science. Advances in bioinformatics led to further understanding of the human gut microbiome. Exponential advances in technology led to a greater knowledge and understanding of the gut microbiomes’ role in health, and disease. The knowledge gained, lead to further understanding of the term dysbiosis (an imbalance of pathogenic gut bacteria). Now, dysbiosis is universally documented as the prime cause for various diseases. The connection between the gut and CKD became evident with the cover article in the Sept/2012 issue of Kidney International. Followed by, the publication of a similar article in Clinical Kidney Journal in 2015. In 1997 Enteric Dialysis® was transformed from a concept into a reality, by Dr. Ranganathan and his research team at Kibow Biotech Inc. After 20 years of R&D, Kibow has used clinical findings of pro/prebiotics to modulate the gut microbiome to improve clinical outcomes in CKD patients worldwide.
Culinary Herbs & Spices as Food and Medicine
Presented by: David Bouley; Carl Germano, CNS, CDN; Marc Grossman, OD, LAc; Mimi Guarneri, MD, FACC, ABOIM; David Perlmutter, MD, FACN, ABIHM; and Robert Silverman, DC, DACBN, DCBCN, MS, CCN, CNS, CSCS, CIISN, CKTP
As practitioners, we all have different approaches to achieving optimal health, but we have a commonality in the human body. This panel of well-known experts will discuss how the silo walls of specialization can be broken down. To provide effective treatment, practitioners must see patients as the whole human body, not as cases involving only a single system. The panel will share their current thinking about how they see the human body holistically and how they search for root causes and resolutions to achieve better outcomes. This discussion will demonstrate how to get past the perceptual limits of silos and specialties and see patients as individuals, not cases.
Presented by: Yehuda Shoenfeld, MD, FRCP, MAACR
Autoimmune diseases are conditions in which the immune system damages normal components of the individual. Thus, autoantibodies productions were found to be multifactorial in their etiology. For practical reasons these factors are classified into four categories: genetic, immune deficiencies, hormonal state, and environmental causes.
This issue highlights advances in integrative healthcare practice, including new discoveries and collaborations across medical fields.
Presented by:
Andrew Weil, MD
Modern scientific medicine has advanced rapidly, but those advances have not resulted in better health or healthcare. Ignoring the healing power of nature and the organism's intrinsic mechanisms of healing have made us dependent on therapeutic interventions requiring technology that is very expensive. The future of medicine is integrative – that is, in the thoughtful combination of conventional and alternative ideas and practices. Integrative medicine takes advantage of natural healing, treats whole persons (bodies, minds, spirits), considers all aspects of lifestyle in matters of health and illness, honors and supports the therapeutic relationship between practitioner and patient, and makes use of all appropriate therapies, using simpler, low-tech methods when possible.
This presentation was recorded at the 2022 Integrative Healthcare Symposium Annual Conference.
Presented by: Hyla Cass, MD
This session will describe the functions of the endocannbinoid system and demonstrate ways to wean patients off opiates and psychiatric medications using cannabidiol (CBD), and identify ways to select CBD products.
We’re in the midst of a growing epidemic of dementia and Alzheimer’s in the ageing population. A growing body of research is highlighting these conditions have a strong association with high blood sugar levels and pre-diabetes, which alarmingly is now seen in almost half of the American population.
PORTFOLIO OF INTEGRATIVE HEALTHCARE MEDIA + EVENTS
